News from the FDA/CDC

FDA strengthens mammography regulations: Final rule


The Food and Drug Administration has made changes to existing mammography regulations.

A final rule, updating the regulations issued under the Mammography Quality Standards Act of 1992, requires that mammography facilities notify patients about the density of their breasts, strengthens the FDA’s oversight of facilities, and provides guidance to help physicians better categorize and assess mammograms, according to a March 9 press release.

The rule requires implementation of the changes within 18 months.

According to the final rule document, the updates are “intended to improve the delivery of mammography services” in ways that reflect changes in mammography technology, quality standards, and the way results are categorized, reported, and communicated to patients and providers.

For instance, mammography reports must include an assessment of breast density to provide greater detail on the potential limitations of the mammogram results and allow patients and physicians to make more informed decisions, such as the possibility of additional imaging for women with dense breast tissue.

“Today’s action represents the agency’s broader commitment to support innovation to prevent, detect and treat cancer,” said Hilary Marston, MD, MPH, FDA’s chief medical officer, in the agency’s press release. The FDA remains “committed to advancing efforts to improve the health of women and strengthen the fight against breast cancer.”

A version of this article first appeared on

Recommended Reading

Myths about smoking, diet, alcohol, and cancer persist
MDedge Internal Medicine
Who’s at higher risk for breast cancer recurrence?
MDedge Internal Medicine
FDA expands abemaciclib use in high-risk early breast cancer
MDedge Internal Medicine
HER2-low breast cancer is not a separate clinical entity: Study
MDedge Internal Medicine
Breast cancer surgery timing matters, but is faster always better?
MDedge Internal Medicine